“An Interim Analysis of a Prospective Observational Study of Upadacitinib in Patients with Atopic Dermatitis with Prurigo Nodules” (2025) SKIN The Journal of Cutaneous Medicine, 9(6), p. s623. doi:10.25251/43885276.